GLP-1 Insurance Appeal Letter Template: Get Coverage Approved For Semaglutide Or Tirzepatide (2026 Guide)
If your insurance denied semaglutide or tirzepatide, you're not alone, and you're not necessarily stuck. Many denials happen for administrative reasons (prior authorization paperwork, step therapy boxes not checked, missing clinical documentation) rather than because you "don't qualify." A well-built appeal package can turn a no into a yes, especially when your documentation clearly matches your plan's medical policy.
This guide gives you a practical, copy-paste GLP-1 insurance appeal letter template, plus the supporting documents and "special situation" language that tends to move appeals forward in 2026. You'll stay factual, match your insurer's criteria, and make it easy for an appeals reviewer to approve coverage.
When A GLP-1 Appeal Makes Sense (And When It Doesn’t)
Appeals work best when the denial is fixable, meaning the plan does cover the medication (or covers it under certain conditions), and your file simply didn't prove you met those conditions.
A GLP-1 appeal often makes sense when:
You have a covered indication under your plan's rules, but the prior authorization (PA) submission was incomplete or missing key details
You meet BMI and comorbidity requirements, but those data weren't documented clearly (or weren't included)
You tried required alternatives (step therapy) and either didn't respond or couldn't tolerate them, but the "try and fail" history wasn't laid out in a way the insurer accepts
You're being labeled "not medically necessary," but your clinical risk factors (A1C, blood pressure, lipids, sleep apnea, fatty liver disease) strongly support treatment
On the other hand, an appeal is less likely to succeed when:
Your plan has an explicit exclusion for anti-obesity medications and you're requesting coverage solely for weight loss, with no relevant coverage pathway
The denial deadline has passed (many plans require submission within 30–180 days)
You don't have provider support. For GLP-1s, a clinician's documentation, especially a Letter of Medical Necessity, often makes or breaks the case
You truly don't meet the plan criteria (for example, BMI thresholds), and your plan does not allow exceptions
The big idea: you're not writing an essay. You're building a clean, evidence-based record that aligns with your insurer's checklist.
Common Denial Reasons: Prior Authorization, Step Therapy, Plan Exclusions, "Not Medically Necessary"
Prior authorization (PA) not approved or incomplete
This is one of the most common scenarios. The insurer may say "PA required" or "information insufficient." Translation: the plan might cover it, but the submission didn't match what they needed.
Step therapy not met
The plan may require that you try cheaper medications first (for diabetes, that often includes metformin: for obesity, it may include other anti-obesity drugs depending on the formulary). If you did try them, your appeal needs dates, doses, outcomes, and side effects.
Plan exclusion ("weight loss drugs excluded")
Some plans exclude anti-obesity medications altogether. If your denial letter uses exclusion language, your pathway may depend on whether your plan covers the medication for diabetes or other medical conditions, or whether an exception process exists.
Not medically necessary
This usually means the insurer believes the documentation didn't prove you meet the plan's definition of medical necessity. That definition is often tied to BMI thresholds, comorbidities, lab values, or prior treatment attempts.
What To Do Before You Write: Gather The Right Documents
Strong appeals are built before you write a single sentence. Your goal is to make the reviewer's job easy: your documentation should answer, in order, "What is the policy requirement?" and "Where is the proof that you meet it?"
If you only do one thing, do this: print or save the plan's criteria, highlight the requirements, and then label your attachments so each requirement has a matching piece of evidence.
Your Denial Letter And Plan Criteria (Formulary, PA Rules, Medical Policy)
Collect and keep these together in one folder (digital or paper):
Denial letter (or Explanation of Benefits, EOB) with the denial reason and appeal instructions
Your plan's drug formulary entry for the specific medication (for example, Wegovy vs Ozempic: Zepbound vs Mounjaro)
The prior authorization form and criteria (often a PDF)
The plan's medical policy for anti-obesity medications and/or diabetes medications
Key details to locate:
Appeal deadline and where to submit (fax, portal upload, mail)
Any required forms (some insurers want an appeal form plus your letter)
The exact criteria language (BMI cutoff, comorbidities list, step therapy requirements, timeframes)
If you can quote your plan's own wording in your appeal, you reduce "interpretation risk." You're not arguing. You're matching.
Clinical Evidence: Diagnosis Codes, Labs, Weight History, And Comorbidities
Your clinical evidence should be specific, dated, and easy to scan.
Common data points that strengthen GLP-1 appeals:
Diagnosis codes (examples that are commonly used)
E66.01: Morbid (severe) obesity due to excess calories
E66.9: Obesity, unspecified
E11.9: Type 2 diabetes mellitus without complications
R73.03: Prediabetes
Weight and BMI history
A dated trend helps: starting weight/BMI, highest documented weight, current weight/BMI, and prior weight-loss attempts.
Labs and vitals
A1C and fasting glucose
Lipids (LDL, triglycerides)
Blood pressure readings and/or hypertension diagnosis
Liver enzymes and imaging/labs consistent with NAFLD (non-alcoholic fatty liver disease) when present
Comorbidities (with documentation)
Hypertension
Dyslipidemia
Obstructive sleep apnea
Prediabetes or type 2 diabetes
NAFLD/NASH
Osteoarthritis pain impacting function
History of gestational diabetes can be relevant for risk framing (include only if documented)
If you're in perimenopause or menopause, document what's measurable (weight trajectory, insulin resistance markers when available, blood pressure, sleep apnea diagnosis), and what's functional (fatigue, joint pain, reduced activity tolerance) without exaggeration.
Provider Support: Chart Notes, Letter Of Medical Necessity, And Visit Summaries
Insurers trust clinician documentation more than patient narrative alone. Ideally, your packet includes:
Chart notes showing diagnosis and clinical rationale
Visit summaries documenting prior medication trials and lifestyle interventions
A Letter of Medical Necessity (LMN) written by your prescriber
A medication history list (including prior anti-obesity meds, diabetes meds, and why they were stopped)
If your provider is willing, ask them to include (or you can request records that already show):
Why a GLP-1 is appropriate now
Why alternatives were ineffective or not tolerated
What monitoring plan is in place (follow-ups, labs, side effect management)
That last point matters. Appeals reviewers are often looking for signs that therapy will be supervised and medically purposeful, not casual or cosmetic.
How To Write A Strong GLP-1 Appeal Letter (Structure That Works)
A strong appeal letter is structured like a clean clinical note: concise, organized, and aligned with policy language.
Aim for 1–2 pages. Attach the evidence: don't bury it inside long paragraphs.
The Core Elements: Patient Story, Medical Rationale, And Policy Match
Use this structure:
- Header and reference information
Your name, date of birth, policy number, group number
Claim number, denial date, medication name and dose requested
Prescriber name/NPI and contact info
- What you're asking for
A clear sentence requesting reversal of the denial and approval of coverage.
- Patient story (brief, factual)
Your diagnosis (obesity, type 2 diabetes, prediabetes, etc.)
Your weight/BMI trajectory
Prior attempts (lifestyle programs, prior medications) and outcomes
- Medical rationale (why this medication)
Your clinical risks and comorbidities
Why delaying treatment increases risk (for example, worsening glycemic control, progressive cardiometabolic risk)
- Policy match (the most important part)
Quote the plan criterion and directly map your evidence to it.
Example of a "policy match" sentence:
My plan's PA criteria state coverage is available for BMI ≥30 with at least one weight-related comorbidity. My BMI is 34.6 (see Attachment C) and I have documented hypertension and obstructive sleep apnea (see Attachments D and E).
- Closing request and availability
Ask for approval, list your attachments, and provide a contact method.
How To Address Step Therapy And "Try And Fail" Requirements
Step therapy denials often succeed on appeal when you present a clean medication timeline.
What insurers typically want to see:
Drug name, dose, start/stop dates
Duration (many policies expect a minimum trial window)
Outcome (ineffective, inadequate response)
Adverse effects (what happened, how severe, whether it resolved after stopping)
Key language that helps (and is honest):
Not tolerated due to documented adverse effects
Contraindicated due to a medical condition or drug interaction (only if your clinician documented this)
Inadequate clinical response after an appropriate trial
If you had GI side effects with metformin or other agents, be specific (nausea, diarrhea, abdominal pain) and tie it to records. Insurers tend to discount vague statements like "couldn't tolerate."
How To Handle "Weight Loss Drugs Are Excluded" Denials
This is the hardest category, and your options depend on what the plan actually excludes.
First, clarify what the medication was prescribed for:
Some GLP-1 medications are labeled and commonly covered under diabetes benefits (for example, Ozempic for type 2 diabetes, Mounjaro for type 2 diabetes).
Others are labeled for chronic weight management (for example, Wegovy, Zepbound), which some plans exclude.
If your denial cites a weight-loss exclusion:
Don't pretend it's not a weight medication if that's what was prescribed.
Do check whether your plan has an exceptions pathway for medical necessity, severe obesity, or high-risk comorbidities.
Do focus on cardiometabolic disease language: obesity is a chronic disease state associated with hypertension, dyslipidemia, insulin resistance, sleep apnea, and fatty liver disease. Your appeal should frame the request as risk reduction and disease management, not aesthetics.
Also consider a practical parallel path: if coverage is impossible under your plan, your clinician may discuss alternative medications, dosing strategies, or different coverage routes. That's outside the appeal letter, but it's worth acknowledging now so you're not putting all your hope into a plan exclusion appeal.
GLP-1 Insurance Appeal Letter Template (Copy, Paste, Customize)
Use this template as a starting point. You'll customize the bracketed fields, attach your evidence, and keep the tone professional and non-emotional.
Template Notes: What To Personalize And What Not To Change
Personalize:
Your identifiers (name, DOB, policy ID)
The medication name and dose
Your diagnoses and key clinical facts (BMI, A1C, comorbidities)
Your prior medication trials and outcomes
The exact plan criteria language and where you found it (quote it)
Try not to change:
Direct quotes from the plan policy (copy exactly)
Objective numbers (dates, labs, BMI). Don't round in a way that makes your file look sloppy
The overall structure. Appeals teams read fast: consistency helps
GLP-1 insurance appeal letter template:
[Your Full Name]
[Your Address]
[City, State ZIP]
[Phone]
[Email]
[Date]
Appeals Department
[Insurance Company Name]
[Insurance Company Address or Fax per denial letter]
Re: Appeal of Denial for [Medication Name: semaglutide/tirzepatide brand], [Dose]
Patient: [Your Name], DOB: [MM/DD/YYYY]
Policy/Member ID: [ID નંબર]
Group #: [#]
Claim #: [#] (if available)
Prescriber: [Clinician Name, Credentials], NPI: [#]
Date of Denial: [MM/DD/YYYY]
Dear Appeals Team,
I am submitting this letter to appeal the denial dated [MM/DD/YYYY] for coverage of [medication name and dose]. I am requesting reversal of the denial and approval of coverage based on medical necessity and my plan's coverage criteria.
Clinical summary
Diagnoses: [List diagnoses and ICD-10 codes if available, e.g., E66.01 severe obesity: I10 hypertension: R73.03 prediabetes: E11.9 type 2 diabetes]
Current anthropometrics: Height [x], Weight [x] on [date], BMI [x] (see Attachment [ ]).
Relevant history and risk: I have [list comorbidities with brief evidence references, e.g., hypertension treated with [med], obstructive sleep apnea diagnosed on [date], dyslipidemia on [date], NAFLD/NASH noted on [date/imaging]]. These conditions increase cardiometabolic risk and are part of the medical rationale for treatment.
Prior treatment attempts (if step therapy applies)
I have completed the following required or clinically appropriate prior therapies:
[Medication/lifestyle program], [dose], [start date–end date], outcome: [ineffective / adverse effects / contraindication]. Documentation included in Attachment [ ].
[Medication/lifestyle program], [dose], [start date–end date], outcome: [ineffective / adverse effects / contraindication]. Documentation included in Attachment [ ].
Policy criteria match
My plan's [medical policy/prior authorization criteria] for [medication name or GLP-1 class] states: "[paste the exact criterion language here]."
I meet this criterion because:
[Bullet: BMI threshold met with dated measurement]
[Bullet: Required comorbidity documented]
[Bullet: Required step therapy completed or not tolerated, with documentation]
[Bullet: Any additional criteria such as enrollment in a weight management program or diabetes criteria]
Request
Given the above, and the supporting documentation enclosed, I respectfully request that you overturn the denial and approve coverage of [medication name] as medically necessary care under my plan.
Attachments included
Attachment A: Denial letter and/or EOB
Attachment B: Plan medical policy/PA criteria excerpt with highlighted requirements
Attachment C: Weight/BMI trend documentation
Attachment D: Relevant labs (A1C, lipids, etc.)
Attachment E: Comorbidity documentation (e.g., hypertension, sleep apnea, NAFLD)
Attachment F: Prescriber Letter of Medical Necessity and supporting chart notes
Attachment G: Medication history and step therapy trial documentation
If additional information is needed, please contact me at [phone/email] or my prescriber's office at [phone]. Thank you for your prompt review.
Sincerely,
[Your Full Name]
[Member ID]
Attachments Checklist To Include With Your Appeal Packet
Use this checklist so nothing important is missing.
Must-have documents:
Denial letter (and the page with appeal instructions)
Your appeal letter (the template above)
Plan criteria excerpts (formulary entry, PA rules, and/or medical policy)
Prescriber Letter of Medical Necessity (LMN)
Chart notes or visit summaries supporting diagnosis, rationale, and monitoring
Weight/BMI history (dated)
Labs relevant to the request (A1C, fasting glucose, lipids: others as applicable)
Medication trials (names, dates, doses, outcomes: include intolerance documentation)
Helpful "extra" documents when applicable:
Sleep study report for obstructive sleep apnea
Blood pressure logs or hypertension medication list
Liver imaging or hepatology notes if NAFLD/NASH is present
A brief symptom/function statement (for example, joint pain limiting activity), especially if documented in notes
If you cite studies, include only a page or two of key abstracts or guideline excerpts. Too much can dilute your strongest evidence.
Sample Language For Special Situations (Pick What Applies)
You can paste these short blocks into the "Clinical summary" or "Policy match" sections. Keep them truthful and consistent with your records.
Prediabetes Or Type 2 Diabetes: A1C, Metformin Intolerance, And Glycemic Risk
If you have type 2 diabetes:
My diagnosis is type 2 diabetes mellitus (E11.9). My most recent hemoglobin A1C is [x]% dated [date] (Attachment [ ]). This indicates suboptimal glycemic control and increased cardiometabolic risk.
If you tried metformin and couldn't tolerate it:
I completed a metformin trial from [date] to [date] at [dose]. The medication was discontinued due to documented gastrointestinal adverse effects (e.g., persistent nausea/diarrhea/abdominal cramping), noted in clinical records (Attachment [ ]). This supports that step therapy requirements were attempted and were not tolerated.
If you have prediabetes:
I have prediabetes (R73.03) with A1C [x]% dated [date] (Attachment [ ]). Given my additional risk factors, my clinician is treating obesity and insulin resistance to reduce progression to type 2 diabetes.
Cardiometabolic Risk: Hypertension, Dyslipidemia, Sleep Apnea, NAFLD/NASH
My obesity is complicated by the following documented cardiometabolic comorbidities: [hypertension on medication(s)], [dyslipidemia], [obstructive sleep apnea], and/or [NAFLD/NASH]. These conditions increase long-term cardiovascular risk and are part of the medical necessity for anti-obesity pharmacotherapy under my plan's criteria.
If sleep apnea is a key comorbidity:
I have obstructive sleep apnea diagnosed on [date] (Attachment [ ]). This is a weight-related comorbidity commonly included in medical necessity criteria for chronic weight management therapy.
If NAFLD/NASH is relevant:
I have documentation consistent with non-alcoholic fatty liver disease (NAFLD) / suspected steatohepatitis (NASH) noted on [date] (Attachment [ ]). Weight reduction and metabolic improvement are clinically indicated to reduce risk of progression.
Perimenopause/Menopause: Weight Trajectory, Insulin Resistance, And Functional Impact
I am in perimenopause/menopause and have experienced a sustained upward weight trajectory even though lifestyle interventions (Attachment [ ]). My clinician is treating obesity as a chronic metabolic condition with associated insulin resistance and cardiometabolic risk. This has had functional impact, including [fatigue/joint pain/reduced activity tolerance], as documented in my medical record (Attachment [ ]).
If your plan requires documentation of prior lifestyle efforts:
I have participated in structured lifestyle interventions, including nutrition and physical activity changes, for [duration]. Even though adherence, I have not achieved clinically meaningful or sustained weight reduction, supporting the need for adjunct pharmacotherapy.
GI Tolerability: Documenting Side Effects, Dose Adjustments, And Supportive Care
If the denial relates to tolerability or discontinuation concerns:
My clinician is monitoring gastrointestinal tolerability and has implemented dose titration and supportive care strategies consistent with prescribing guidance. Any adverse effects have been documented with dates, severity, and response to dose adjustments (Attachment [ ]). This supports that therapy is supervised and medically managed.
If you had GI intolerance with prior medications:
Prior therapy was limited by gastrointestinal intolerance documented in chart notes (Attachment [ ]). This history is clinically relevant when evaluating alternative therapies and step requirements.
One practical tip: the strongest tolerability documentation reads like a timeline, not a paragraph. Dates, doses, symptoms, action taken, outcome.
Submitting The Appeal And Following Up (So It Doesn’t Get Lost)
Even a perfect letter can fail if it's sent to the wrong place or missed by a deadline. Treat submission like you're sending something time-sensitive for work: track it, confirm it, document every touchpoint.
Where To Send It, Deadlines, And How To Confirm Receipt
Follow the denial letter instructions exactly. Common submission options include:
Upload through the member portal
Fax to a dedicated appeals number
Mail to an appeals address
If mail is allowed, consider a method that provides delivery confirmation. If fax is used, keep the fax confirmation page.
Checklist for a clean submission:
Send to the correct department (Appeals vs Prior Authorization)
Use the claim number and denial reference on every page if possible
Include a simple cover page listing the documents included
Keep a copy of everything you send
Write down:
Date submitted
Method (portal upload/fax/mail)
Confirmation number, upload receipt, or tracking number
Name of any representative you spoke with
Then follow up. If you don't have receipt confirmation within a few business days, call and ask:
Can you confirm the appeal was received?
Is it marked complete, or is anything missing?
What is the expected decision timeframe?
If You're Denied Again: External Review, Peer-To-Peer, And State Protections
A second denial isn't the end of the road.
Depending on your plan type and state, next steps may include:
Peer-to-peer review
Your prescriber speaks directly with the insurer's medical reviewer. This can be effective when the issue is clinical nuance or misinterpretation of your documentation.
Second-level internal appeal
Some plans allow multiple internal appeals. Confirm timelines and requirements.
External review
Many plans offer an independent external review after internal appeals are exhausted. The denial letter should outline how to request it.
State protections and complaint pathways
States often have an insurance department that accepts complaints, especially if you believe the plan didn't follow its own policy or didn't process the appeal appropriately.
A realistic note: success rates vary widely by plan design. Appeals tend to do best when your documentation clearly matches written criteria, and when your clinician is actively engaged in the process.
Conclusion
A GLP-1 denial feels personal, but it's usually procedural. Your advantage is that you can be more organized than the original paperwork that triggered the denial. When you build an appeal packet that mirrors your plan's criteria, highlighted policy language, a short factual narrative, and clean attachments, you give the reviewer a straightforward path to approval.
If you're preparing an appeal, set yourself up to win by focusing on two things: clarity and documentation. And don't underestimate follow-up. Appeals don't always fail: sometimes they just disappear into the wrong queue.
GI side effects don't have to be the price of admission for GLP-1 therapy. Casa de Sante offers physician-formulated gut support products built for the specific digestive challenges these medications create. Explore your options at casadesante.com.
This article is for educational purposes only and is not medical advice. Always consult your healthcare provider before making changes to your treatment plan.
GLP-1 Insurance Appeal Letter FAQs
What is a GLP-1 insurance appeal letter template and why is it important?
A GLP-1 insurance appeal letter template is a structured, evidence-based letter used to challenge insurance denials for medications like semaglutide or tirzepatide. It aligns clinical facts with the insurer's criteria to increase the chance of approval for coverage.
When should I consider filing an appeal for a denied GLP-1 medication?
Appeals make sense if your plan covers the medication under certain conditions but the initial submission lacked key info, such as clinical documentation, prior authorization, or evidence of step therapy trials. Provider support and meeting plan criteria are crucial for success.
What key documents should I gather before writing a GLP-1 appeal letter?
Collect the denial letter, your insurance plan’s medical policy and prior authorization criteria, clinical evidence like diagnosis codes, weight/BMI history, labs (A1C, lipids), provider notes, and a Letter of Medical Necessity. Proper documentation helps match policy requirements with your case.
How do I address step therapy requirements in my GLP-1 appeal letter?
Detail the alternative medications tried, including drug names, doses, start and stop dates, outcomes, and any adverse effects. Clearly document intolerance or inadequate response, supported by clinical records, to meet the insurer’s step therapy criteria.
Can GLP-1 medications be denied due to plan exclusions, and how can I appeal those denials?
Yes, some plans exclude anti-obesity drugs for weight loss but may cover GLP-1s for diabetes or cardiometabolic conditions. An appeal should emphasize medical necessity based on comorbidities like hypertension or sleep apnea, framing treatment as risk reduction rather than cosmetic.
